What Is the Pancreas?

The pancreas is a glandular organ in the abdomen that serves two distinct physiological roles: as an exocrine organ, it secretes digestive enzymes into the small intestine; as an endocrine organ, it regulates blood glucose concentration by releasing the hormones insulin and glucagon from clusters of cells called the islets of Langerhans. The endocrine function is central to the IEEE Technology Navigator context, where the pancreas appears as a subject of biomedical engineering research focused on glucose sensing, automated insulin delivery, and the design of closed-loop control systems that replicate or replace pancreatic function in people with diabetes mellitus.

Approximately 537 million adults worldwide live with diabetes, a condition in which pancreatic insulin production is impaired or absent (Type 1) or insufficient relative to insulin resistance (Type 2). This scale of unmet medical need has driven engineering research across sensor design, control theory, pharmacokinetic modeling, and implantable device development. The interplay between biochemical measurement and feedback control makes the pancreas a rich problem domain for electrical, systems, and biomedical engineers.

Continuous Glucose Monitoring

Closed-loop glucose management depends on accurate, real-time measurement of blood glucose levels. Continuous glucose monitors (CGMs) place a thin electrochemical electrode just below the skin surface, where it oxidizes interstitial glucose to generate a current proportional to concentration. Modern CGM devices, such as the Dexcom G6 and similar designs, sample glucose every few minutes and transmit readings wirelessly, eliminating the need for manual finger-stick calibration. Remaining engineering challenges include sensor drift, where the device signal shifts from true glucose values over hours, and the approximately 10-minute lag between interstitial and blood glucose due to diffusion across the capillary-tissue boundary. IEEE Spectrum coverage of the artificial pancreas provides a detailed account of how CGM technology has evolved and where performance gaps remain.

Closed-Loop Insulin Delivery

The artificial pancreas integrates a CGM, a control algorithm, and an insulin infusion pump into a feedback loop that adjusts basal insulin delivery automatically. The control algorithm, running on the pump processor or a paired smartphone, uses a model of human glucose-insulin dynamics to predict future blood glucose and compute corrective insulin doses. Commercial systems such as Medtronic's MiniMed 780G and Tandem's Control-IQ adjust the pump's basal rate every five minutes and issue corrective boluses when predicted glucose exceeds target thresholds. These systems are classified as hybrid closed-loop because they require the user to announce meals for optimal pre-prandial dosing; fully automated systems that handle meal disturbances without user input remain an active research goal. The PMC study on dual-hormone model predictive control for artificial pancreas systems demonstrates an approach that adds glucagon delivery alongside insulin to broaden the controllable range.

Pancreatic Imaging and Surgical Engineering

The pancreas is also a subject of medical imaging research, where computed tomography, magnetic resonance imaging, and endoscopic ultrasound are used to detect pancreatic cancer, pancreatitis, and cystic lesions. Pancreatic ductal adenocarcinoma has one of the lowest five-year survival rates among solid tumors, partly because it is rarely detected before it has spread; improving automated segmentation and lesion detection in pancreatic CT scans is an active area in medical image computing. Robotic-assisted pancreatectomy systems, which operate through small incisions using articulated surgical instruments, represent a separate engineering thread focused on improving surgical access to this deep-seated organ, as documented in JMIR Diabetes research on multi-input artificial pancreas systems.

Applications

The pancreas is relevant to technology development in a range of fields, including:

• Closed-loop artificial pancreas systems for Type 1 diabetes management
• Continuous glucose sensor design and electrochemical transduction
• Model predictive control and pharmacokinetic modeling for insulin delivery
• Medical image segmentation for pancreatic cancer detection
• Robotic-assisted minimally invasive pancreatic surgery systems